atorvastatin has been researched along with Infections, Staphylococcal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghorbani, R; Nassaji, M; Saboori Shkofte, H | 1 |
Arslan, Z; Balta, S; Kucuk, HO; Kucuk, U | 1 |
Desplaces, N; Gabignon, C; Le Guyader, N; Lidove, O; Zeller, V; Ziza, JM | 1 |
3 other study(ies) available for atorvastatin and Infections, Staphylococcal
Article | Year |
---|---|
Previous Atorvastatin Treatment and Risk of Diabetic Foot Infection in Adult Patients: A Case-control Study.
Topics: Atorvastatin; Case-Control Studies; Diabetic Foot; Dyslipidemias; Female; Humans; Immunologic Factors; Iran; Male; Middle Aged; Prevalence; Risk Factors; Staphylococcal Infections; Treatment Outcome | 2017 |
Antistaphylococcal action of statins is worthy in infections after coronary artery bypass grafting.
Topics: Anti-Bacterial Agents; Atorvastatin; Coronary Artery Bypass; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Xanthophylls | 2015 |
[Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Creatine Kinase; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Weakness; Prosthesis-Related Infections; Pyrroles; Rhabdomyolysis; Staphylococcal Infections | 2013 |